Absorption |
Blood-Brain Barrier | BBB- | 0.9041 |
Human Intestinal Absorption | HIA+ | 0.9957 |
Caco-2 Permeability | Caco2+ | 0.8346 |
P-glycoprotein Substrate | Substrate | 0.7522 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9017 |
Non-inhibitor | 0.8313 |
Renal Organic Cation Transporter | Non-inhibitor | 0.6180 |
Distribution |
Subcellular localization | Lysosome | 0.5035 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7999 |
CYP450 2D6 Substrate | Non-substrate | 0.8480 |
CYP450 3A4 Substrate | Non-substrate | 0.5895 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8330 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8611 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8814 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7717 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8609 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7240 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8819 |
Non-inhibitor | 0.8685 |
AMES Toxicity | AMES toxic | 0.7906 |
Carcinogens | Non-carcinogens | 0.8923 |
Fish Toxicity | High FHMT | 0.9991 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9293 |
Honey Bee Toxicity | Low HBT | 0.8852 |
Biodegradation | Not ready biodegradable | 1.0000 |
Acute Oral Toxicity | III | 0.7524 |
Carcinogenicity (Three-class) | Non-required | 0.5795 |